Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2013:2013:576479.
doi: 10.1155/2013/576479. Epub 2013 Oct 9.

Potential effects of medicinal plants and secondary metabolites on acute lung injury

Affiliations
Review

Potential effects of medicinal plants and secondary metabolites on acute lung injury

Daniely Cornélio Favarin et al. Biomed Res Int. 2013.

Abstract

Acute lung injury (ALI) is a life-threatening syndrome that causes high morbidity and mortality worldwide. ALI is characterized by increased permeability of the alveolar-capillary membrane, edema, uncontrolled neutrophils migration to the lung, and diffuse alveolar damage, leading to acute hypoxemic respiratory failure. Although corticosteroids remain the mainstay of ALI treatment, they cause significant side effects. Agents of natural origin, such as medicinal plants and their secondary metabolites, mainly those with very few side effects, could be excellent alternatives for ALI treatment. Several studies, including our own, have demonstrated that plant extracts and/or secondary metabolites isolated from them reduce most ALI phenotypes in experimental animal models, including neutrophil recruitment to the lung, the production of pro-inflammatory cytokines and chemokines, edema, and vascular permeability. In this review, we summarized these studies and described the anti-inflammatory activity of various plant extracts, such as Ginkgo biloba and Punica granatum, and such secondary metabolites as epigallocatechin-3-gallate and ellagic acid. In addition, we highlight the medical potential of these extracts and plant-derived compounds for treating of ALI.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Ashbaugh DG, Bigelow DB, Petty TL, Levine BE. Acute respiratory distress in adults. The Lancet. 1967;2(7511):319–323. - PubMed
    1. Eves ND, Song Y, Piper AA, Maher TM. Year in review 2012: acute lung injury, interstitial lung diseases, sleep and physiology. Respirology. 2013;18(3):555–573. - PubMed
    1. Donahoe M. Acute respiratory distress syndrome: a clinical review. Pulmonary Circulation. 2011;1:192–211. - PMC - PubMed
    1. Randhawa R, Bellingan G. Acute lung injury. Anaesthesia and Intensive Care Medicine. 2007;8(11):477–480.
    1. Zilberberg MD, Epstein SK. Acute lung injury in the medical ICU—comorbid conditions, age, etiology, and hospital outcome. American Journal of Respiratory and Critical Care Medicine. 1998;157(4):1159–1164. - PubMed

Publication types

MeSH terms

LinkOut - more resources